Capital market transactions

  • An NYSE-listed national medical group in connection in its private offerings of US$1 billion and US$750 million unsecured senior notes under Rule 144A
  • A NASDAQ‐listed diversified healthcare company in its public offering of US$200 million convertible notes
  • A NASDAQ-listed women's healthcare company in connection with public offerings and at the market offerings of common stock totaling more than US$650 million
  • An Israeli biopharmaceutical company in connection with its initial public offering and follow-on offering on the NASDAQ Capital Market
  • An NYSE-listed REIT in connection with multiple public and private offerings of common stock and secondary offerings of common stock by selling stockholders totaling more than US$650 million
  • An NYSE-listed REIT in connection with public offerings of US$250 million and US$300 million of senior unsecured notes
  • The gaming division of a Native American tribe in connection with a US$367 million private offering of taxable and tax-exempt notes
  • An NYSE-listed diversified specialty contractor in connection with a US$115 million public offering of convertible notes and concurrent secondary offering of common stock by selling shareholders
  • An institutional investor as selling stockholder in a US$165 million public offering of an NYSE-listed independent oil and natural gas company
  • Private investors in connection with a PIPE offering in and acquisition of control of an NYSE American-listed developer and marketer of premium spirits

Mergers and acquisitions

  • A leading FinTech company in its US$800 million business combination with an NYSE-listed special purpose acquisition company
  • A technology-enabled provider of value-based healthcare in its business combination with a NASDAQ-listed special purpose acquisition company valuing the combined enterprise at US$800 million
  • An NYSE-listed healthcare company in the divestiture of its radiology and AI-assisted teleradiology business for US$885 million
  • An NYSE-listed multinational biopharmaceutical and diagnostics company in its US$1.5 billion acquisition of a NASDAQ-listed diagnostic laboratory company
  • A NASDAQ‐listed multinational biopharmaceutical and diagnostics company in its US$60 million acquisition of a NASDAQ‐listed biopharmaceutical development company
  • A private-equity backed technology-enabled provider of health system performance optimization solutions in connection with its sale to a new sponsor
  • A private-equity backed professional employer organization in connection with a management buyout backed by a new sponsor
  • A private-equity backed business process outsourcing company in connection with its sale to a new sponsor
  • A leading InsureTech company in connection with its acquisition of a business-to-business insurance agency from a leading global insurance broker and associated debt and equity financing
  • The special committee of a NASDAQ-listed agricultural company in its review of strategic alternatives

Debt financings

  • An NYSE-listed national medical group in connection with its US$500 million, US$800 million and US$2.0 billion unsecured revolving credit facilities and US$1.9 billion unsecured revolving credit facility and term loan
  • A leading FinTech lender in connection with multiple credit facilities, warehouse facilities and other structured financing arrangements
  • A leading InsureTech company in connection with senior and subordinated credit facilities
  • A NASDAQ-listed women's healthcare company in connection with US$200 million and US$300 million in senior secured credit facilities
  • An NYSE-listed REIT in connection with its US$575 million unsecured revolving credit facility and US$250 million unsecured term loan
  • A privately-held business process outsourcing company in connection with numerous secured revolving credit facilities and term loans

Venture capital/minority investments/joint ventures

  • A non-profit organization with over US$2 billion in assets in connection with more than 40 venture capital investment transactions
  • A leading InsureTech company in connection with a highly structured minority investment
  • A leading InsureTech company in connection with a joint venture and technology licensing transaction
  • A technology-based education company in connection with capital raising and debt financing transactions